Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,518 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Effect of Adjunctive Mangosteen Pericarp on Cognition in People With Schizophrenia: Secondary Analysis of a Randomized Controlled Trial.
Marx W, Skvarc DR, Mohebbi M, Walker AJ, Meehan A, Turner A, Baker A, Dodd S, Cotton SM, Scott JG, Kavanagh BE, Ashton MM, Brown E, McGrath JJ, Berk M, Dean OM. Marx W, et al. Among authors: baker a. Front Psychiatry. 2021 Jun 15;12:626486. doi: 10.3389/fpsyt.2021.626486. eCollection 2021. Front Psychiatry. 2021. PMID: 34211410 Free PMC article.
The efficacy of sodium benzoate as an adjunctive treatment in early psychosis - CADENCE-BZ: study protocol for a randomized controlled trial.
Ryan A, Baker A, Dark F, Foley S, Gordon A, Hatherill S, Stathis S, Saha S, Bruxner G, Beckman M, Richardson D, Berk M, Dean O, McGrath J, Group CW, Scott J. Ryan A, et al. Among authors: baker a. Trials. 2017 Apr 7;18(1):165. doi: 10.1186/s13063-017-1908-5. Trials. 2017. PMID: 28388932 Free PMC article. Clinical Trial.
CoMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapine.
Siskind D, Friend N, Russell A, McGrath JJ, Lim C, Patterson S, Flaws D, Stedman T, Moudgil V, Sardinha S, Suetani S, Kisely S, Winckel K, Baker A. Siskind D, et al. Among authors: baker a. BMJ Open. 2018 Mar 2;8(3):e021000. doi: 10.1136/bmjopen-2017-021000. BMJ Open. 2018. PMID: 29500217 Free PMC article. Clinical Trial.
Protocol and Rationale: A 24-week Double-blind, Randomized, Placebo Controlled Trial of the Efficacy of Adjunctive Garcinia mangostanaLinn. (Mangosteen) Pericarp for Schizophrenia.
Turner A, McGrath JJ, Dean OM, Dodd S, Baker A, Cotton SM, Scott JG, Kavanagh BE, Ashton MM, Walker AJ, Brown E, Berk M. Turner A, et al. Among authors: baker a. Clin Psychopharmacol Neurosci. 2019 May 31;17(2):297-307. doi: 10.9758/cpn.2019.17.2.297. Clin Psychopharmacol Neurosci. 2019. PMID: 30905130 Free PMC article.
Protocol update and statistical analysis plan for CADENCE-BZ: a randomized clinical trial to assess the efficacy of sodium benzoate as an adjunctive treatment in early psychosis.
Lim C, Baker A, Saha S, Foley S, Gordon A, Ward D, Burgher B, Dark F, Beckmann M, Stathis S, Bruxner G, Ryan A, Richardson D, Hatherill S, Berk M, Dean O, McGrath J; Cadence Working Group; Scott J. Lim C, et al. Among authors: baker a. Trials. 2019 Apr 8;20(1):203. doi: 10.1186/s13063-019-3232-8. Trials. 2019. PMID: 30961658 Free PMC article.
Effect of Sodium Benzoate vs Placebo Among Individuals With Early Psychosis: A Randomized Clinical Trial.
Scott JG, Baker A, Lim CCW, Foley S, Dark F, Gordon A, Ward D, Richardson D, Bruxner G, Beckmann KM, Hatherill S, Stathis S, Dixon K, Ryan AE, McWhinney BC, Ungerer JPJ, Berk M, Dean OM, Saha S, McGrath J. Scott JG, et al. Among authors: baker a. JAMA Netw Open. 2020 Nov 2;3(11):e2024335. doi: 10.1001/jamanetworkopen.2020.24335. JAMA Netw Open. 2020. PMID: 33170261 Free PMC article. Clinical Trial.
Adjunctive Garcinia mangostana Linn. (Mangosteen) Pericarp for Schizophrenia: A 24-Week Double-blind, Randomized, Placebo Controlled Efficacy Trial: Péricarpe d'appoint Garcinia mangostana Linn (mangoustan) pour la schizophrénie : un essai d'efficacité de 24 semaines, à double insu, randomisé et contrôlé par placebo.
Turner A, Baker A, Dean OM, Walker AJ, Dodd S, Cotton SM, Scott JG, Kavanagh BE, Ashton MM, Brown E, McGrath JJ, Berk M. Turner A, et al. Among authors: baker a. Can J Psychiatry. 2021 Apr;66(4):354-366. doi: 10.1177/0706743720982437. Epub 2020 Dec 23. Can J Psychiatry. 2021. PMID: 33355478 Free PMC article. Clinical Trial.
Cannabidiol for at risk for psychosis youth: A randomized controlled trial.
Amminger GP, Lin A, Kerr M, Weller A, Spark J, Pugh C, O'Callaghan S, Berger M, Clark SR, Scott JG, Baker A, McGregor I, Cotter D, Sarnyai Z, Thompson A, Yung AR, O'Donoghue B, Killackey E, Mihalopoulos C, Yuen HP, Nelson B, McGorry PD. Amminger GP, et al. Among authors: baker a. Early Interv Psychiatry. 2022 Apr;16(4):419-432. doi: 10.1111/eip.13182. Epub 2021 Jun 30. Early Interv Psychiatry. 2022. PMID: 34190422 Clinical Trial.
CoMET: a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapine.
Siskind D, Russell AW, Suetani S, Flaws D, Kisely S, Moudgil V, Northwood K, Robinson G, Scott JG, Stedman T, Warren N, Winckel K, Cosgrove P, Baker A. Siskind D, et al. Among authors: baker a. Ther Adv Psychopharmacol. 2021 Oct 16;11:20451253211045248. doi: 10.1177/20451253211045248. eCollection 2021. Ther Adv Psychopharmacol. 2021. PMID: 34671454 Free PMC article.
4,518 results